Skip to content

Feasibility of Continuous Noninvasive Finger Arterial Blood Pressure Measurement for Detection and Staging of Aortic Stenosis

Feasibility of Continuous Noninvasive Finger Arterial Blood Pressure Measurement for Detection and Staging of Aortic Stenosis

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT03088787
Acronym
COaRt
Enrollment
100
Registered
2017-03-23
Start date
2017-04-01
Completion date
2018-12-31
Last updated
2018-05-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Aortic Stenosis, Calcific

Brief summary

The primary purpose of this study is electronic data collection of arterial pressure waveform signals in patients with Aortic Stenosis. The collected digital pressure waveform data will be used to assess the feasibility of using the arterial pressure signal as a decision support tool for early detection of aortic stenosis conditions. Furthermore we evaluate hemodynamic parameters before and after valve repair and its correlation with outcome.

Interventions

DEVICENexfin measuremtents

There will be only observational recordings, no interevntion

Sponsors

Edwards Lifesciences
CollaboratorINDUSTRY
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Healthy volunteers
No

Inclusion criteria

* o Patients with severe senile degenerative aortic valve stenosis * Clinical team agrees on eligibility including assessment that TAVR is appropriate for the subject * Patients undergoing TAVR via the femoral approach * Patients who normally require a guiding catheter for central aortic pressure monitoring during the TAVR procedure * Patient must be 18 years old or older * Patient, or legally authorized representative, has given consent to be in the study * Patient height and weight are available prior to study * Ability to perform a Nexfin measurement at the left hand side.

Exclusion criteria

* o Patients with contraindications for placement of aortic catheter * Patients with mixed aortic valve disease (aortic stenosis and aortic regurgitation with predominant aortic regurgitation \>3+). * Aortic valve is a congenital unicuspid or congenital bicuspid valve, or is noncalcified * Patients being treated with an intra-aortic balloon pump * Patients less than 40 kg in weight * Female patients of childbearing potential with a known pregnancy * Patient is currently participating in an investigational drug or another device study that clinically interferes with the study endpoints

Design outcomes

Primary

MeasureTime frameDescription
the distinctive morphological characteristics of the aortic pressure waveformDuring procedure and 4 hours afterthe distinctive morphological characteristics of the aortic pressure waveform

Secondary

MeasureTime frame
changes in hemodynamic variables after TAVR and its influence on cardiac recovery.during procedure and up to 6 weeks after intervention

Countries

Netherlands

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 11, 2026